EAM
STTK icon

Exome Asset Management’s Shattuck Labs STTK Stock Holding History

Exome Asset Management’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-223,300
Closed -$1.59M – 72
2023
Q4 		$1.59M Buy
+223,300
New +$609K 1.57% 27

Other funds holding STTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Exome Asset Management's STTK Position: Q1 2024 in Review

Exome Asset Management sold out of Shattuck Labs (STTK) in Q1 2024, closing a stake of 223,300 shares — an estimated $1.59M sold.

Exome Asset Management first reported a position in STTK in Q4 2023 and held it in 1 quarter. The position peaked at $1.59M in Q4 2023. 69 funds tracked by Wall St. Rank hold STTK as of Q1 2024.

  • Exome Asset Management reported no remaining Shattuck Labs position as of Q1 2024 after selling out during the quarter.
  • Exome Asset Management sold 223,300 Shattuck Labs shares in Q1 2024, an estimated $1.59M.
  • Exome Asset Management first reported a position in Shattuck Labs in Q4 2023 and held it in 1 quarter.
  • Exome Asset Management's Shattuck Labs position peaked at $1.59M in Q4 2023.
  • 69 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2024.

Based on Exome Asset Management's 13F filing for Q1 2024, filed 15 May 2024.